Duavee FDA Approval History
FDA Approved: Yes (First approved October 3, 2013)
Brand name: Duavee
Generic name: bazedoxifene and conjugated estrogens
Dosage form: Tablets
Company: Pfizer Inc.
Treatment for: Postmenopausal Symptoms, Prevention of Osteoporosis
Duavee (bazedoxifene and conjugated estrogens) is an estrogen agonist/antagonist and conjugated estrogens combination indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause, and prevention of postmenopausal osteoporosis in women with an intact uterus.
Development timeline for Duavee
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
